Syngenta is preparing plans for one of the largest initial public offerings in Hong Kong in recent years, as strengthening market conditions and renewed investor confidence revive the city’s fundraising landscape.

The Switzerland-based agrochemicals and seeds group, owned by China National Chemical Corporation, is advancing discussions with advisers over a potential multi-billion-dollar share sale in the territory.

The move follows an earlier attempt to list in mainland China that was put on hold, with Hong Kong now emerging as the preferred venue amid improving liquidity and stronger equity valuations.

Market participants say the transaction could rank among the biggest offerings in the city since the post-pandemic slowdown, signalling a broader revival in capital markets activity.

Hong Kong has seen a rebound in trading turnover and renewed interest from institutional investors seeking exposure to Chinese and regional growth stories.

Syngenta, one of the world’s largest agricultural technology companies, produces crop protection chemicals and seeds used globally.

The proposed listing would provide fresh capital to support research, product development and international expansion, while also helping to optimise its capital structure.

The company’s move comes as global investors reassess opportunities in Asian equities, encouraged by stabilising economic data and supportive policy measures.

Bankers note that large, internationally recognised issuers can act as bellwethers for market recovery, potentially paving the way for additional sizeable listings.

Analysts caution that timing will remain sensitive to global market volatility and geopolitical developments, but say that sustained inflows and improved sentiment have created a more favourable window for high-profile offerings.

If completed at the expected scale, Syngenta’s flotation would reinforce Hong Kong’s re-emergence as a leading venue for global equity fundraising.